Home › Free Stock Grades › NVAX
Novavax, Inc. (NVAX) Stock Grade
NVAX · Healthcare
A+
Market Cap
$1.1B
P/E Ratio
2.5
Revenue Growth (YoY)
+64.7%
Net Margin
39.2%
Return on Equity
—
Dividend Yield
None
About Novavax, Inc.'s fundamentals
Novavax generates strong revenue growth at 64.7% year-over-year and maintains an impressive net profit margin of 39.2%, indicating efficient conversion of sales into earnings. The company's P/E ratio of 2.5 suggests it is trading at a low valuation multiple relative to current earnings. With a market capitalization of $1.1 billion and no dividend payment, the company appears to be reinvesting profits into operations rather than returning capital to shareholders.